Mather Group, Llc. Atri Cure, Inc. Transaction History
Mather Group, Llc.
- $8.58 Billion
- Q1 2025
A detailed history of Mather Group, Llc. transactions in Atri Cure, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 183 shares of ATRC stock, worth $5,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183
Previous 63
190.48%
Holding current value
$5,746
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
52MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$148 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$145 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$115 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$94.2 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$76.5 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.46B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...